AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
5min chapter
#68 – IDWeek 2022 Recap: Late Breaking Trials and Pipeline Antibacterials
Breakpoints
ABX01 - A Novel Immunotherapy to Treat Gram Negative Infections
A novel immunotherapy to treat gram negative infections developed by Centari therapeutics called ABX01. This is still in the molecule number and letter phase, but very, very excited. And they looked at this using knockout mice so that neutropenic mice and they saw about a two log drop in bacterial colony forming units alone. They added in the antibody response and they got an additional three log kill. It's remniscent of some of the data we talked about in early ECMA episodes from a couple of years ago about using these immunotherapies as adjunct agents for bacteremia.
00:00
Transcript
Episode notes
Get the Snipd
podcast app
Unlock the knowledge in podcasts with the podcast player of the future.
AI-powered
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode
Save any
moment
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Share
& Export
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode